ACER THERAPEUTICS INC. Share-based Payment Arrangement, Expense
ACER THERAPEUTICS INC. reported Share-based Payment Arrangement, Expense of $232.52 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-20
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $232.52K, a 49.46% decline year-over-year.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $259.90K, a 43.59% decline year-over-year.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $285.51K, a 39.78% decline year-over-year.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $445.51K, a 16.35% decline year-over-year.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2022 was $1.84M, a 19.52% decline from fiscal 2021.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2021 was $2.29M, a 2.83% increase from fiscal 2020.
- ACER THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2020 was $2.22M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 116 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $232.52K 10-Q · filed 2023-11-20 | $492.43K derived: sum of 2 quarters · filed 2023-11-20 | $777.93K 10-Q · filed 2023-11-20 | $1.22M derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2023-06-30 | $259.90K 10-Q · filed 2023-08-14 | $545.41K 10-Q · filed 2023-08-14 | $990.92K derived: sum of 3 quarters · filed 2023-08-14 | $1.45M derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2023-03-31 | $285.51K 10-Q · filed 2023-05-15 | $731.02K derived: sum of 2 quarters · filed 2023-05-15 | $1.19M derived: sum of 3 quarters · filed 2023-11-20 | $1.65M derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2022-12-31 | $445.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $905.63K derived: sum of 2 quarters · filed 2023-11-20 | $1.37M derived: sum of 3 quarters · filed 2023-11-20 | $1.84M 10-K · filed 2023-03-27 | ||
| 2022-09-30 | $460.12K 10-Q · filed 2023-11-20 | $920.89K derived: sum of 2 quarters · filed 2023-11-20 | $1.39M 10-Q · filed 2023-11-20 | $1.93M derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2022-06-30 | $460.78K 10-Q · filed 2023-08-14 | $934.87K 10-Q · filed 2023-08-14 | $1.47M derived: sum of 3 quarters · filed 2023-08-14 | $2.07M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $474.10K 10-Q · filed 2023-05-15 | $1.01M derived: sum of 2 quarters · filed 2023-05-15 | $1.61M derived: sum of 3 quarters · filed 2023-05-15 | $2.20M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $532.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $1.13M derived: sum of 2 quarters · filed 2023-03-27 | $1.73M derived: sum of 3 quarters · filed 2023-03-27 | $2.29M 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $600.01K 10-Q · filed 2022-11-14 | $600.31K 10-Q · filed 2021-11-19 | $1.19M derived: sum of 2 quarters · filed 2022-11-14 | $1.75M 10-Q · filed 2022-11-14 | $2.22M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $594.66K 10-Q/A · filed 2022-11-14 | $1.15M 10-Q/A · filed 2022-11-14 | $1.62M derived: sum of 3 quarters · filed 2022-11-14 | $2.11M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $559.44K 10-Q · filed 2022-05-16 | $1.03M derived: sum of 2 quarters · filed 2022-05-16 | $1.51M derived: sum of 3 quarters · filed 2022-05-16 | $2.12M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $465.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $953.23K derived: sum of 2 quarters · filed 2022-03-02 | $1.56M derived: sum of 3 quarters · filed 2022-03-02 | $2.22M 10-K · filed 2022-03-02 | ||
| 2020-09-30 | $487.40K 10-Q · filed 2021-11-19 | $1.09M derived: sum of 2 quarters · filed 2021-11-19 | $1.76M 10-Q · filed 2021-11-19 | |||
| 2020-06-30 | $603.57K 10-Q/A · filed 2021-11-19 | $1.27M 10-Q/A · filed 2021-11-19 | ||||
| 2020-03-31 | $667.34K 10-Q/A · filed 2021-11-19 | |||||
| 2019-09-30 | $564.02K 10-Q · filed 2020-11-10 | $1.28M derived: sum of 2 quarters · filed 2020-11-10 | $1.95M 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | $715.37K 10-Q · filed 2020-08-13 | $1.39M 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | $671.93K 10-Q · filed 2020-05-14 | |||||
| 2018-09-30 | $352.72K 10-Q · filed 2019-11-13 | $679.14K derived: sum of 2 quarters · filed 2019-11-13 | $931.52K 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | $326.43K 10-Q · filed 2019-08-13 | $578.80K 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | $252.37K 10-Q · filed 2019-05-14 | |||||
| 2017-09-30 | $106.00K 10-Q · filed 2018-11-09 | $120.74K derived: sum of 2 quarters · filed 2018-11-09 | $136.62K 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $14.74K 10-Q · filed 2018-08-13 | $30.62K 10-Q · filed 2018-08-13 | ||||
| 2016-09-30 | $143.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $332.11K derived: sum of 2 quarters · filed 2016-11-14 | $485.96K 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $188.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $342.71K 10-Q · filed 2016-08-11 | ||||
| 2016-03-31 | $153.85K 10-Q · filed 2016-05-12 | |||||
| 2015-06-30 | $205.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $472.35K 10-Q · filed 2016-08-11 | ||||
| 2015-03-31 | $266.95K 10-Q · filed 2016-05-12 | |||||
| 2014-03-31 | $331.03K 10-Q · filed 2014-05-14 | |||||
| 2012-09-30 | $542.77K 10-Q · filed 2012-11-14 | $16.12M 10-Q · filed 2012-11-14 | ||||
| 2011-09-30 | $385.81K 10-Q · filed 2012-11-14 |